MIRA INFORM REPORT
|
Report Date : |
26.08.2011 |
IDENTIFICATION DETAILS
|
Name : |
REFASA S.A.C. |
|
|
|
|
Formerly Known As : |
REPRESENTACIONES FARMACEUTICAS S.A. |
|
|
|
|
Registered Office : |
Enrique Villanueva 105, Urb. Juan Pablo de Monterrico, Surco, Postal Code Lima,33 |
|
|
|
|
Country : |
Peru |
|
|
|
|
Financials (as on) : |
31.12.2008 |
|
|
|
|
Date of Incorporation : |
09.10.1956 |
|
|
|
|
Com. Reg. No.: |
Card 1, Page 258, Volume 313 (1956) |
|
|
|
|
Legal Form : |
Closely-held Corporation |
|
|
|
|
Line of Business : |
importer of medicines, representing initially important Japanese and
European laboratories |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$190,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
Peru |
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
IDENTIFICATION
|
CORRECT
COMPANY NAME |
:
|
REFASA S.A.C. |
|
TRADE
NAME |
:
|
N/A" |
|
TAXPAYER
REGISTRATION |
:
|
RUC 20100151970 |
|
MAIN
ADDRESS |
:
|
Enrique Villanueva 105, Urb.
Juan Pablo de Monterrico, Surco, |
|
POSTAL
CODE |
:
|
Lima,33 |
|
CITY |
:
|
Lima |
|
DEPARTMENT/STATE |
:
|
Lima |
|
COUNTRY |
:
|
PERU |
|
TELEPHONE |
:
|
6103100 - 2755100 - 2754111 |
|
FAX |
:
|
2754868 |
|
WEB
SITE |
:
|
SUMMARY
FOUNDATION :
1956
LAST CAPITAL :
S/.12,000,000.= Nuevos Soles
SHAREHOLDERS '
EQUITY :
S/.16,483,000.= Nuevos Soles (As of 31.12.2007)
SALES :
31,500,000.00
EMPLOYEES :
69
PAYMENTS :
Usually to terms/good
CHIEF EXECUTIVE :
PORTUGAL SIGNORI, RAUL EDUARDO
DISPOSITION :
PARTIAL (Full information but no figures).
LEGAL
BACKGROUNDS
|
LEGAL
ESTATUS |
:
|
Closely-held Corporation |
|
DATE
OF INCORPORATION |
:
|
09OCT1956 |
|
START
OF OPERATIONS |
:
|
09/10/1956 |
|
REGISTERED
IN |
:
|
Lima |
|
NOTARY
OFFICE |
:
|
Guillermo Ureta |
|
DURATION |
:
|
Indefinite |
|
REGISTRATION |
:
|
Card 1, Page 258, Volume 313
(1956) |
|
INITIAL
CAPITAL |
:
|
S/.12,000,000.= Nuevos Soles |
|
CURRENT PAID-IN CAPITAL |
:
|
S/.12,000,000.= Nuevos Soles |
|
LAST CAPITAL INCREASE |
:
|
No increase reported |
|
SHAREHOLDERS' EQUITY |
:
|
S/.16,483,000.= Nuevos Soles
(As of 31.12.2007) |
|
TYPE OF SHARES |
:
|
Registered |
|
LISTED AT STOCK EXCHANGE |
:
|
No |
|
SHARE
VALUE |
:
|
S/.1.= Nuevo Sol |
|
CURRENT
EXCHANGE RATE |
:
|
S/.2.74 per US$1.00 |
|
MEMBERSHIP |
:
|
N/A |
COMMENTS
.-
According to SUNAT (National Tax Authority) the
Company was incorporated in the Good Taxpayer System (R.S.037-2002) as from
June 1st, 2002.
DIRECTORS
/ EXECUTIVES / SHAREHOLDERS
|
FULL
NAMES / COMPANY NAME |
TITLE |
OWNERSHIP
% |
|
PORTUGAL SIGNORI, RAUL
EDUARDO |
Executive President/Rep. |
60% |
|
DEL RIO JIMENEZ, GUSTAVO
EDUARDO |
Adm. & Finance Manager |
|
|
VERA CASTAŃEDA, LUIS
HUMBERTO |
General Accountant |
|
|
MALDONADO AQUIJE, ZOILA
GIOVANA |
Representative |
|
WHO
IS WHO?
PORTUGAL
SIGNORI, RAUL EDUARDO
NATIONALITY : Peruvian
BORN : 18FEB1944
DOC OF IDENT. : DNI 09179043
PROFESSION : Pharmaceutical Chemist
HOME ADDRESS : Gondomar 158-170, Urb. La Estancia, La Molina, Lima
TLF : 4359767 - 4791128
CIVIL STATUS : Married to Frances de Portugal
BACKGROUND INFORMATION .-
His Tax ID No. (RUC) 10091790438 has been CANCELLED
since 06.09.1998.
Associated
as per our database to :
|
Company |
Position |
Tax.
Reg. |
Country |
|
PROVEEDORES HOSPITALARIOS
S.A. |
Shareholder |
20100157153 |
PERU |
|
LABORATORIOS DANIEL A.
CARRION S.A.C. |
Executive President |
20100284937 |
PERU |
|
PUBLIMEDIC S.A.C. |
Executive President |
20101144462 |
PERU |
|
ABBA S.A.C. |
President |
20172899260 |
PERU |
|
LOANDRE S.A. |
General Manager |
20101645160 |
PERU |
Subject
is reported to participate or have participated in :
|
Company |
Position |
Country |
|
HERPOR REPRESENTACIONES SRL
(BAJA DEFINITIVA) |
Manager |
|
DEL
RIO JIMENEZ, GUSTAVO EDUARDO
NATIONALITY : Peruvian
BORN : 15OCT1961
DOC OF IDENT. : DNI 08804919
BACKGROUND INFORMATION .-
He has no Tax ID.
VERA
CASTAĂ‘EDA, LUIS HUMBERTO
BORN : 17AUG1958
DOC OF IDENT. : DNI 06175312
TAX ID : 10061753121
PROFESSION : Public Accountant
Associated
as per our database to :
|
Company |
Position |
Tax.
Reg. |
Country |
|
PUBLIMEDIC S.A.C. |
Representative |
20101144462 |
PERU |
|
LABORATORIOS DANIEL A.
CARRION S.A.C. |
General Manager |
20100284937 |
PERU |
MALDONADO
AQUIJE, ZOILA GIOVANA
NATIONALITY : Peruvian
DOC OF IDENT. : DNI 06744049
TAX ID : 10067440493
Associated
as per our database to :
|
Company |
Position |
Tax.
Reg. |
Country |
|
LABORATORIOS DANIEL A.
CARRION S.A.C. |
Representative |
20100284937 |
PERU |
BUSINESS
HISTORY
REFASA S.A.C. was formed on 09.10.1956 under the
name REPRESENTACIONES FARMACEUTICAS S.A., and later, in June 1998, it adopted
the current name REFASA S.A.C., before
Anibal Corvetto, Notary Public.
This Company was established as an importer of
medicines, representing initially important Japanese and European laboratories.
Over the years and due to changes in industrial legislation,
it was forced to acquire an industrial plant to manufacture products that were
imported. For that reason, in 1968, it acquired Laboratorios D.A. Carrión S.A.,
which is a national laboratory where several pharmaceuticals are produced and
sold by Refasa S.A.C.
REAFASA has a stake in LABORATORIOS DANIEL A.
CARRION S.A.C. and has invested for
S/.5,475,000.= Nuevos Soles.
RELATED
COMPANIES TO SUBJECT COMPANY OR TO MAJORITY SHAREHOLDER
|
COMPANY NAME |
COUNTRY |
AX. REG. |
RELATION |
|
ABBA S.A.C. |
PERU |
20172899260 |
Related |
|
LABORATORIOS DANIEL A.
CARRION S.A.C. |
PERU |
20100284937 |
Related |
|
PUBLIMEDIC S.A.C. |
PERU |
20101144462 |
Related |
BUSINESS
MAIN
ACTIVITY .-
REFASA S.A.C. is engaged in the import, trade, distribution
and representation of pharmaceuticals and toiletries.
It is also dedicated to producing pharmaceuticals
through third-parties.
IMPORT : Yes
Argentina,
Austria, Belgium, Brazil, China, Colombia, France, Germany, India,
Italy,
Japan, Korea, Spain, Switzerland, USA
Annual Imports in US$ (CIF) :
Year
Monto
2011 1,042,400.00
2010 1,543,007.00
2009 1,622,946.00
2008 1,840,802.00
2007 2,231,326.00
2006 2,191,944.00
EXPORT : Yes
Argentina
Annual Exports in US$ (FOB) :
Year
Monto
2011 194,984.00
2010 32,100.00
2008 100,439.00
2007 37,000.00
2006 9,980.00
|
% CASH SALES/METHOD |
:
|
30% |
|
% CREDIT SALES/TERMS |
:
|
70% (Inv./30 days and/or
Draft/30,40,45 days) |
|
% FOREIGN SALES (COUNTRIES) |
:
|
25% |
|
% DOMESTIC PURCHASES |
:
|
10% |
|
%
FOREIGN PURCHASES |
:
|
90% |
|
SELLING
TERRITORY |
:
|
Domestic market - 75% |
|
EMPLOYEES |
:
|
69 |
LOCATION
.-
|
Premises |
:
|
Rented |
|
Monthly
Amount |
:
|
N/A |
|
Time
Occupied |
:
|
N/A |
|
Area |
:
|
800 m2 |
|
Floors |
:
|
3 |
Remarks and other Premises .-
Headquarters, administrative and commercial offices
are located at the above address.
Premises are owned by ABBA S.A.C.
Formerly, they were located at Callee Uno y Morro Solar
A, Int.7, Urb. Juan Pablo, San Borja, Lima.
No other facilities have been found.
FINANCIAL
INFORMATION
|
Interviewee(s) |
:
|
Luis Humberto Vera Castańeda |
|
Position(s) |
:
|
Accountant |
|
Cooperation |
:
|
PARTIAL (Full information
but no figures). |
|
Information
Provided |
:
|
Mr. Vera updated some information,
confirmed other data, and agreed to provide the financials as soon as possible. In case of favorable answer, additional
information will be sent immediately, if not, consider this report
definitive. In the meantime, we have
completed this report based on data we gathered from reliable outside sources
where no updated balance sheets could be obtained. We only knew that Turnover
2009 came to S/.32,765,470.= Nuevos Soles.
Latest available figures kept in our files are Balance Sheets for the
FY as of 31/12/2008 y 31/12/2007, expressed in Nuevos Soles, included for
reference purposes. |
BALANCE
SHEET
|
BALANCE SHEET DATE |
31DEC2008 |
31DEC2007 |
|
|
|
PERIOD |
12
months |
12
months |
|
|
|
EXCHANGE RATE PER US$ |
3.12 |
2.98 |
|
|
|
CURRENCY |
Nuevo
Sol |
Nuevo
Sol |
|
|
|
ASSETS |
|
|
|
|
|
TOTAL CURRENT |
19,893,000.00 |
17,688,000.00 |
|
|
|
FIXED |
2,327,000.00 |
1,676,000.00 |
|
|
|
OTHERS |
5,475,000.00 |
4,486,000.00 |
|
|
|
TOTAL ASSETS |
27,695,000.00 |
23,850,000.00 |
|
|
|
LIABILITIES |
|
|
|
|
|
TOTAL CURRENT |
6,838,000.00 |
7,339,000.00 |
|
|
|
LONG TERM |
34,000.00 |
28,000.00 |
|
|
|
SHAREHOLDERS' EQUITY |
|
|
|
|
|
TOTAL
EQUITY |
20,823,000.00 |
16,483,000.00 |
|
|
|
TOTAL
LIABILITIES |
27,695,000.00 |
23,850,000.00 |
|
|
|
SALES |
31,500,000.00 |
31,665,000.00 |
|
|
|
PROFIT(LOSS) |
2,158,000.00 |
2,224,000.00 |
|
|
RATIO
|
LIQUIDITY RATIO |
2.91 |
(Current Assets/Current
Liabilities) |
|
DEBT-TO-EQUITY RATIO |
304.52 |
(Shareholders's
equity/Current Liabilities %) |
|
PROFITABILITY MARGIN |
6.85 |
(Profits/Sales %) |
|
WORKING CAPITAL |
13,055,000.00 |
(Current Assets - Current
Liabilities) |
FINANCIAL
SITUATION : UNDETERMINED
Financial standing is deemed to be indeterminate
because no updated accounting elements were available to evaluate its current
results. Balance Sheet as of 31/12/2008
was satisfactory. Sales exceeded US$10 Million Dollars and Final results were
favorable at the end of said period. In
addition, found out Turnover 2009 came to S/.32,765,470.= Nuevos Soles
(equivalent to US$11,376,899.,30 Dollars).
According to specialized sources, no negative
backgrounds have been reported, meanwhile, the Superintendency of Bank and
Insurance - SBS, rated this Company 100%
Normal.
INSURANCE
.-
|
Company |
Againts |
Amount |
Expiration |
|
RIMAC INTERNACIONAL CIA.DE
SEG.Y REASEG. |
All risk |
N/A |
|
PAYMENTS
RECORD
TRADE REFERENCES .-
|
Supplier |
Country |
Tel. |
Line of Credit |
Monthly Average |
Terms(days) |
Perfomance? |
Time |
Products/Services |
|
Ag Ad Quelopana y Caballero SAC |
PERU |
511 4570367 |
US$ 30,000.= |
|
Draft/90 days |
Prompt |
Sv.years |
Customs services |
NOTE: Other Suppliers did not
provide information or could not be consulted.
|
Supplier |
Country |
Tel. |
|
Despachos Aduanales SA |
PERU |
511 2640044 |
|
Rhenochem |
SWITZERLAND |
N/A |
|
Takeda Chemical Industries |
JAPAN |
N/A |
|
Bracco Industria Quimica |
ITALY |
N/A |
|
Andenex Chemie |
GERMANY |
N/A |
|
Arco Pharma |
FRANCE |
N/A |
|
Unigraf S.A.C. |
PERU |
511 2417478 |
|
Termoencogibles del Perú
S.A. |
PERU |
511 4229228 |
CREDIT RISK CENTRAL .-
So far, no protested documents, NSF checks,
cancelled accounts or lawsuits have been reported. Found neither compulsory
collection debts, nor payment failures against the State.
LAWSUITS .-
No legal actions or claims
have been filed against this Company.
BANKING
INFORMATION
BANKERS
.-
|
Bank |
Contact |
Telephone |
Account # |
DC (S/.) |
FC (US$) |
|
SCOTIABANK PERU SAA |
N/A |
N/A |
N/A |
N/A |
N/A |
|
BBVA CONTINENTAL |
N/A |
N/A |
164-1-0-22574 |
N/A |
N/A |
|
INTERBANK |
N/A |
N/A |
N/A |
N/A |
N/A |
The Company deals with the above entities where it holds
current accounts. Credit facilities have been granted. Good credit experience.
Further details were not available.
Debt structure for Bank
(Domestic Currency)
|
Bank |
% Debt Rating |
Current Debt DC |
Current Debt FC |
|
SCOTIABANK |
NORMAL |
2604498 |
0 |
|
BBVA CONTINENTAL |
NORMAL |
2230957 |
0 |
|
INTERBANK |
NORMAL |
244940 |
0 |
RATING
DESCRIPTION ACCORDING TO THE SBS
Normal .- Good Financial Situation,
Prompt payments, consistent Information, Increasing Trend, Creditworthy.
Potential Problem .- Satisfactory Financial Situation
but cash flow can be weak. Irregular payments. Irregular Trend.
Deficient .-Financial Situation, cash problems, profits shortage, delayed and overdue
payments.
Doubtful .- Heavy Financial Situation, liquidity
shortage, notorious delayed payments, Judicial Collection, Bad Management.
Loss .- Bad Financial Situation,
Insufficient funds, declared
bankruptcy,debt default.
GENERAL
INFORMATION
REPUTATION
.-
NOTHING
AGAINST COMPANY
CREDIT
OPINION
Requested
Credit : MAXIMUM
CREDIT
Suggested
Credit : US$190,000.=
NOTE: The Opinion given is confidential referential
and with out liability
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.46.13 |
|
UK Pound |
1 |
Rs.75.52 |
|
Euro |
1 |
Rs.66.53 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history (10%) Market
trend (10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.